KEZUTIN 4 G/0,5 G INF PLV SOL 10
Rychlý přehled
| Dosage form | Powder solution infusion |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | No, it does not. Maximální doplatek: Lék nemá stanovenou úhradu. Maximální cena: Informace o maximální ceně není dostupná. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Sodná sůl piperacilinu (4,17 g), piperacilin (4 g), sodná sůl tazobaktamu (0,54 g), tazobaktam (0,5 g), hydrogenuhličitan sodný. More information about the composition can be found in the SPC, section 6.1. |
| Dostupnost / výpadek | Obnoveno The latest report from the manufacturer is from 20. 5. 2026. Výroba je obnovena od 20. 5. 2026. |
| Kód SÚKL | 0264344 |
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Does the medicine have reimbursement from public health insurance?
No, it does not.
Which medical specialist may prescribe KEZUTIN?
Prescription is not conditional on a medical specialization.
What is the composition of KEZUTIN?
Sodná sůl piperacilinu (4,17 g), piperacilin (4 g), sodná sůl tazobaktamu (0,54 g), tazobaktam (0,5 g), hydrogenuhličitan sodný. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to KEZUTIN?
The medicine belongs to ATC group J01CR05 – Piperacilin a enzymový inhibitor. Medicines with the same active substance can be found here.
Who manufactures KEZUTIN?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 20. 5. 2026. Production has been resumed as of 20. 5. 2026.
What is the unique code for KEZUTIN?
The medicine has code 0264344. Code details can be found here.
How many packs of KEZUTIN were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of KEZUTIN were previously dispensed on request forms in Czechia?
The page was last updated on 17. 07. 2026